HomeInvestors HealthDisc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) Disc Medicine stock rallies 26% on FDA update for bitopertin (NASDAQ:IRON) By BOMAR ENT. November 4, 2024 FacebookTwitterPinterestWhatsApp JHVEPhoto Disc Medicine (NASDAQ:IRON) stock soared 26% Monday after the company said there was a potential to apply for FDA accelerated approval of its drug bitopertin for the treatment of erythropoietic protoporphyria, or EPP, based on existing data. Disc (IRON Source link Previous articleOPTIONS TRADING: A Beginners Crash Course [8 BOOKS in 1] | Including Trading Journal Log Book for Stock Trading and InvestingNext articleToday in history: Financial Insight finance #newspaper #history #history #ai #today latest articles explore more United Airlines’ New Policy Could Get Passengers Permanently Banned AI BOT TRADING FOR BEGINNERS (PLUS PREMIUM BOT): The Ultimate Guide To Maximizing Profits Forex Trading Journal: Trading Log & Trade Strategy Planner for Forex Traders to Record Trades and Trading Strategies | Record Up to 500 Trades Trading: Basic, Intermediate, Advanced and Strategy Guide to Crash It with Day Trading The Due Diligence Item That Makes or Breaks Cash Flow After Closing Stocks End Mixed as Risk-On Rally Falters Late: Stock Market Today LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
